Trade names from 'sulfuric' to 'sigida' - Electronic medicinal guide TALKDRUGS

Ointment for external use 33.3%.
Ointment for external use.
25 g, 30 g, 40 g, 50 g
. Ointment for external use 33.3%.
Film coated tablets, 25 mg, 100 mg and 200 mg.
AstraZeneca UK Ltd United Kingdom

The tablets of the prolonged action, covered with a film membrane, on 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

AstraZeneca UK Ltd United Kingdom

Capsules with powder for inhalation 50 + 100 μg, 50 + 250 μg, 50 + 500 μg.

Cipla Ltd. India
Solution for external use 2%.
Cream for external use 2%.

Tablets 0.25 mg.
Tablets 0.5 mg.
Tablets 0.75 mg.
Tablets 1.0 mg.

Novartis Pharma AG Switzerland
Tablets are dispersible 0.1 mg.
Tablets are dispersible 0.25 mg.

Novartis Pharma AG Switzerland

Capsules of prolonged action 500 mg.

Tablets 1 mg, 2 mg, 5 mg, 10 mg. For 10 tablets in a blister of PVC / PVDC / / aluminum foil. 3 blisters together with instructions for use
Tablets coated with a film coating of 200 mg.


Tablets, film-coated 2.5 mg, 5 mg.For 14 tablets per blister, consisting of aluminum laminated foil and film
Eli Lilly East SA Switzerland

The drops are nasal.

Nasal drops, 0.01%, 0.025% and 0.05%.

Tablets of 5 mg.

Solution for intravenous and intramuscular injection 5 mg / ml.

Solution for intravenous and intramuscular injection 5 mg / ml in ampoules of 2 ml.
Pills. For 10, 15, 20, 30 tablets in a contour cell box made of a polyvinyl chloride film and aluminum foil foil

Capsules with powder for inhalation, 50 mcg.


Novartis Pharma AG Switzerland

Tablets, film-coated, 200 mg.

Bayer Pharma AG Germany

Liofilizate for the preparation of concentrate for the preparation of solution for infusion, 200 mg.

Bayer Pharma AG Germany

Eye drops 0.1% + 0.033%.

Eye drops, 0.05%.